PRT12396
PRT12396-01
Phase 1 small_molecule active
Quick answer
PRT12396 for Polycythemia Vera (PV) is a Phase 1 program (small_molecule) at Prelude Therapeutics Inc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Prelude Therapeutics Inc
- Indication
- Polycythemia Vera (PV)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active